Conversely, the elevated rate of missing BNP and NT-proBNP data was associated with the patients’ respective hospitalization periods, which coincided with the period of transition in heart failure biomarker recommendations due to the introduction of angiotensin receptor neprilysin inhibitors. This evidence concerns the gene NPPB and heart failure.